Welcome to LookChem.com Sign In|Join Free
  • or
N-[3-(2-ethoxy-2-hydroxyacetyl)-phenyl]-benzenesulphonamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

868601-06-3

Post Buying Request

868601-06-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

868601-06-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 868601-06-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,8,6,0 and 1 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 868601-06:
(8*8)+(7*6)+(6*8)+(5*6)+(4*0)+(3*1)+(2*0)+(1*6)=193
193 % 10 = 3
So 868601-06-3 is a valid CAS Registry Number.

868601-06-3Relevant academic research and scientific papers

Novel Beta-Agonists, Method for Producing Them and Their Use as Drugs

-

Page/Page column 7, (2008/12/04)

Compounds of the formula which are selective beta-3-agonists and useful for the treatment of obesity and type II diabetes. Exemplary compounds are: ethyl 3-{3-[(R)-2-(3-benzenesulphonylamino-phenyl)-2-hydroxy-ethylamino]-3-methyl-butyl}-3H-imidazo[4,5-b]p

Novel Beta-Agonists, Process for Their Preparation and Their Use as Medicaments

-

Page/Page column 9, (2009/01/20)

Compounds of general formula (I) which are selective beta-3-agonists and useful for the treatment of obesity and type II diabetes. Exemplary compounds are: [4-(1-{3-[2-(3-phenylsulphonylamino-phenyl)-2-hydroxy-ethylamino]-3-methyl-butyl}-1H-imidazol-4-yl)

Indol-containing beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions

-

Page/Page column 10, (2010/11/27)

The present invention relates to new beta-agonists of general formula (I) wherein the groups R1 and R2 have the meanings given in the claims and specification, the tautomers, racemates, enantiomers, diastereomers, solvates, hydrates,

Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions

-

Page/Page column 11-12, (2010/11/27)

The present invention relates to new beta-agonists of general formula (I) wherein the groups R1 to R4 have the meanings given in ths claims and specification, the tautomers, racemates, enantiomers, diastereomers, solvates, hydrates,

NOVEL BETA AGONISTS, METHOD FOR PRODUCING THE SAME AND THEIR USE AS DRUGS

-

Page/Page column 35, (2010/02/14)

The invention relates to the novel beta agonists of general formula (I); wherein the groups R1 to R7 are defined as in the claims and the description, and to the tautomers, enantiomers, diastereomers, mixtures, prodrugs and salts the

Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions

-

Page/Page column 14, (2010/02/14)

The present invention relates to new beta-agonists of general formula (I) wherein the groups R1 to R7 have the meanings given in the claims and specification, the tautomers, the enantiomers, the diastereomers, the mixtures thereof, t

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 868601-06-3